AAAAAA
Results:
1-25
|
Results: 25
Authors:
Wu, L
Rappaport, DC
Hanbidge, A
Merchant, N
Shepherd, FA
Greig, PD
Citation: L. Wu et al., Lymphoproliferative disorders after liver transplantation: imaging features, ABDOM IMAG, 26(2), 2001, pp. 200-206
Authors:
Breathnach, OS
Freidlin, B
Conley, B
Green, MR
Johnson, DH
Gandara, DR
O'Connell, M
Shepherd, FA
Johnson, BE
Citation: Os. Breathnach et al., Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results, J CL ONCOL, 19(6), 2001, pp. 1734-1742
Authors:
Schuler, M
Herrmann, R
De Greve, JLP
Stewart, AK
Gatzemeier, U
Stewart, DJ
Laufman, L
Gralla, R
Kuball, J
Buhl, R
Heussel, CP
Kommoss, F
Perruchoud, AP
Shepherd, FA
Fritz, MA
Horowitz, JA
Huber, C
Rochlitz, C
Citation: M. Schuler et al., Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study, J CL ONCOL, 19(6), 2001, pp. 1750-1758
Authors:
Shepherd, FA
Citation: Fa. Shepherd, Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer, SEMIN ONCOL, 28(2), 2001, pp. 30-37
Authors:
Shepherd, FA
Fossella, FV
Lynch, T
Armand, JP
Rigas, JR
Kris, MG
Citation: Fa. Shepherd et al., Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials, SEMIN ONCOL, 28(1), 2001, pp. 4-9
Authors:
Shepherd, FA
Dancey, J
Arnold, A
Neville, A
Rusthoven, J
Johnson, RD
Fisher, B
Eisenhauer, E
Citation: Fa. Shepherd et al., Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma - A study of the National Cancer Institute of Canada Clinical Trials Group, CANCER, 92(3), 2001, pp. 595-600
Authors:
Shepherd, FA
Citation: Fa. Shepherd, Chemotherapy for advanced non-small-cell lung cancer: Modest progress, many choices, J CL ONCOL, 18(21), 2000, pp. 35S-38S
Authors:
Shepherd, FA
Hammershaimb, L
Kim, YS
Citation: Fa. Shepherd et al., Docetaxel as second-line chemotherapy for non-small-cell lung cancer - In reply, J CL ONCOL, 18(21), 2000, pp. 3738-3739
Authors:
Shepherd, FA
Dancey, J
Ramlau, R
Mattson, K
Gralla, R
O'Rourke, M
Levitan, N
Gressot, L
Vincent, M
Burkes, R
Coughlin, S
Kim, Y
Berille, J
Citation: Fa. Shepherd et al., Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy, J CL ONCOL, 18(10), 2000, pp. 2095-2103
Authors:
Shepherd, FA
Abratt, R
Crino, L
Green, M
Sandler, A
Steward, W
Iglesias, J
Anglin, G
Citation: Fa. Shepherd et al., The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer, LUNG CANC, 30(2), 2000, pp. 117-125
Authors:
Hsieh, ETK
Shepherd, FA
Tsao, MS
Citation: Etk. Hsieh et al., Co-expression of epidermal growth factor receptor and transforming growth factor-alpha is independent of ras mutations in lung adenocarcinoma, LUNG CANC, 29(2), 2000, pp. 151-157
Authors:
Dancey, JE
Shepherd, FA
Paul, K
Sniderman, KW
Houle, S
Gabrys, J
Hendler, AL
Goin, JE
Citation: Je. Dancey et al., Treatment of nonresectable hepatocellular carcinoma with intrahepatic Y-90-microspheres, J NUCL MED, 41(10), 2000, pp. 1673-1681
Authors:
Thomas, P
Khokha, R
Shepherd, FA
Feld, R
Tsao, MS
Citation: P. Thomas et al., Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer, J PATHOLOGY, 190(2), 2000, pp. 150-156
Authors:
Murray, N
Livingston, RB
Shepherd, FA
James, K
Zee, B
Langleben, A
Kraut, M
Bearden, J
Goodwin, JW
Grafton, C
Turrisi, A
Walde, D
Croft, H
Osoba, D
Ottaway, J
Gandara, D
Citation: N. Murray et al., Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group, J CL ONCOL, 17(8), 1999, pp. 2300-2308
Authors:
Michael, M
Babic, B
Khokha, R
Tsao, M
Ho, J
Pintilie, M
Leco, K
Chamberlain, D
Shepherd, FA
Citation: M. Michael et al., Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer, J CL ONCOL, 17(6), 1999, pp. 1802-1808
Authors:
von Pawel, J
Schiller, JH
Shepherd, FA
Fields, SZ
Kleisbauer, JP
Chrysson, NG
Stewart, DJ
Clark, PI
Palmer, MC
Depierre, A
Carmichael, J
Krebs, JB
Ross, G
Lane, SR
Gralla, R
Citation: J. Von Pawel et al., Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer, J CL ONCOL, 17(2), 1999, pp. 658-667
Authors:
Quon, H
Shepherd, FA
Payne, DG
Coy, P
Murray, N
Feld, R
Pater, J
Sadura, A
Zee, B
Citation: H. Quon et al., The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer, INT J RAD O, 43(1), 1999, pp. 39-45
Authors:
Rasul, I
Shepherd, FA
Kamel-Reid, S
Krajden, M
Pantalony, D
Heathcote, EJ
Citation: I. Rasul et al., Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia, HEPATOLOGY, 29(2), 1999, pp. 543-547
Authors:
Crump, M
Gospodarowicz, M
Shepherd, FA
Citation: M. Crump et al., Lymphoma of the gastrointestinal tract, SEMIN ONCOL, 26(3), 1999, pp. 324-337
Authors:
Shepherd, FA
Citation: Fa. Shepherd, Chemotherapy for non-small cell lung cancer: Have we reached a new plateau?, SEMIN ONCOL, 26(1), 1999, pp. 3-11
Authors:
Rabkin, CS
Shepherd, FA
Wade, JA
Citation: Cs. Rabkin et al., Human herpesvirus 8 and renal transplantation, N ENG J MED, 340(13), 1999, pp. 1045-1046
Authors:
Catzavelos, C
Tsao, MS
DeBoer, G
Bhattacharya, N
Shepherd, FA
Slingerland, JM
Citation: C. Catzavelos et al., Reduced expression of the cell cycle inhibitor p27(Kip1) in non-small celllung carcinoma: A prognostic factor independent of ras, CANCER RES, 59(3), 1999, pp. 684-688
Authors:
Goodwin, PJ
Shepherd, FA
Citation: Pj. Goodwin et Fa. Shepherd, Economic issues in lung cancer: A review, J CL ONCOL, 16(12), 1998, pp. 3900-3912
Authors:
Latreille, J
Gelmon, KA
Hirsh, V
Laberge, F
Maksymiuk, AW
Shepherd, FA
Delorme, F
Berille, J
Citation: J. Latreille et al., Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience, INV NEW DR, 16(3), 1998, pp. 265-270
Authors:
Shepherd, FA
Payne, DG
Feld, R
Murray, N
Siu, L
Quon, H
Pater, J
Zee, B
Citation: Fa. Shepherd et al., Combined modality therapy for elderly patients with limited small cell lung cancer, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 249-259
Risultati:
1-25
|